Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01659125 |
|
Recruitment Status :
Completed
First Posted : August 7, 2012
Results First Posted : January 7, 2016
Last Update Posted : January 7, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Obsessive-Compulsive Disorder | Behavioral: "OCFighter" | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 26 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD |
| Study Start Date : | August 2012 |
| Actual Primary Completion Date : | June 2014 |
| Actual Study Completion Date : | June 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: OCFighter
OCFighter
|
Behavioral: "OCFighter"
OCFighter™ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD. The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).
Other Names:
|
- Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [ Time Frame: Baseline (pretreatment), 17-weeks (posttreatment), and 6 month-follow-up ]The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.
- Responder Status [ Time Frame: Week 17 (post-treatment) and 6-month follow-up ]Participants who experienced a clinically significant change in Y-BOCS score defined as posttreatment YBOCS score that (a) has decreased by a reliable level (at least 1.96 times the standard deviation of that measure, taking into account the reliability of the measure itself; in this case, a decrease of 5 points or more), and (b) is within the nonclinical range of scores (in this case, a score of 13 or below).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 69 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Principal or co-principal diagnosis of OCD
- Clinical global impression score greater than or equal to 4
- Y-BOCS score great than or equal to 8
- Fluency in English
- Capacity to understand the nature of the study and willingness to sign informed consent form
Exclusion Criteria:
- Active manic episode, psychosis, pervasive developmental disorder, mental retardation
- Concurrent OCD psychotherapy
- Current threat of harm to self or others
- Previous adequate trial of therapist-administered or self-administered exposure and response prevention for OCD
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01659125
| United States, Connecticut | |
| Hartford Hospital | |
| Hartford, Connecticut, United States, 06106 | |
| Principal Investigator: | Gretchen Diefenbach, Ph.D. | Hartford Hospital |
| Responsible Party: | Hartford Hospital |
| ClinicalTrials.gov Identifier: | NCT01659125 |
| Other Study ID Numbers: |
DIEF003581HI |
| First Posted: | August 7, 2012 Key Record Dates |
| Results First Posted: | January 7, 2016 |
| Last Update Posted: | January 7, 2016 |
| Last Verified: | December 2015 |
|
Compulsive Personality Disorder Obsessive-Compulsive Disorder Personality Disorders Mental Disorders Anxiety Disorders |

